Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7789]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
The Global Atlas of palliative care at the end of life
Dr Stephen Connor - Worldwide Hospice Palliative Care Alliance, London, UK
The Global Atlas of palliative care at the end of life ( Dr Stephen Connor - Worldwide Hospice Palliative Care Alliance, London, UK )
28 Mar 2017
Mechanisms of resistance in triple negative breast cancer
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Mechanisms of resistance in triple negative breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
24 Mar 2017
The All.Can initiative
Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland
The All.Can initiative ( Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland )
24 Mar 2017
Cyclin dependent kinases to treat metastatic breast cancer
Dr Sibylle Loibl - German Breast Group
Cyclin dependent kinases to treat metastatic breast cancer ( Dr Sibylle Loibl - German Breast Group )
24 Mar 2017
De-escalating and escalating surgery in the management of early breast cancer
Dr Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA
De-escalating and escalating surgery in the management of early breast cancer ( Dr Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA )
24 Mar 2017
Personalising breast cancer therapies
Dr Philip Poortmans - Institut Curie, Paris, France
Personalising breast cancer therapies ( Dr Philip Poortmans - Institut Curie, Paris, France )
23 Mar 2017
Editor's Choice for March 2017
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for March 2017 ( Prof Gordon McVie - Editor in Chief, ecancer )
23 Mar 2017
CDK 4/6 inhibitors for metastatic breast cancer
Dr Giuseppe Curigliano, Dr Carmen Criscitiello, Dr Ghadeer Shubassi, Prof...
CDK 4/6 inhibitors for metastatic breast cancer ( Dr Giuseppe Curigliano, Dr Carmen Criscitiello, Dr Ghadeer Shubassi, Prof Pierfranco Conte )
20 Mar 2017
Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic...
Dr Noopar Raje - Massachusetts General Hospital, Boston, USA
Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma ( Dr Noopar Raje - Massachusetts General Hospital, Boston, USA )
4 Mar 2017
Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed...
Dr Suzanne Lentzsch - Columbia University, New York, USA
Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed or refractory myeloma ( Dr Suzanne Lentzsch - Columbia University, New York, USA )
3 Mar 2017
Impact of recurrent myeloma alterations on drug response
Dr Muntasir Mamun Majumder - University of Helsinki, Helsinki, Finland
Impact of recurrent myeloma alterations on drug response ( Dr Muntasir Mamun Majumder - University of Helsinki, Helsinki, Finland )
3 Mar 2017
Is precision myeloma medicine more hype than reality?
Dr Suzanne Lentzsch - Columbia University, New York, USA
Is precision myeloma medicine more hype than reality? ( Dr Suzanne Lentzsch - Columbia University, New York, USA )
3 Mar 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation